April 16, 2014
A Massachusetts federal judge rejected six bids by Centocor Ortho Biotech Inc. to toss allegations that its rheumatoid arthritis drug Simponi infringes Abbott Biotechnology Ltd.'s Humira patents, ruling Wednesday that the Johnson & Johnson unit hasn't shown the asserted patent claims are invalid.